The XpresSpa Group announced this week the addition of a new rapid antigen test pilot program at its XpresCheck locations through an agreement with Delta Air Lines for customers traveling from John F. Kennedy International Airport (JFK) to Milan Malpensa (MXP) and Rome –Fiumicino International (FCO) airports.
The new tests, administered through XpresCheck, allow customers eligible to travel to Italy to avoid the mandatory 14-day quarantine on arrival, following a rigorous testing protocol before and after travel.
“This new single-use rapid antigen test is an important addition to our lineup, as it is more economical and easy to administer, allowing us to test more passengers faster,” said XpresSpa CEO Doug Satzman. “XpresCheck’s agreement with Delta Air Lines to administer rapid antigen testing to customers traveling from New York JFK’s Terminal 4 helps increase traveler safety and restore confidence in airline travel in a more efficient way at XpresCheck sites.”
